Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals
  • Print
  • Share
  • E-mail
-
Generic Name: 21-amino acid peptide targeting expanded CAG repeat RNA
Date Designated: 08/03/2026
Orphan Designation: treatment of Huntington's disease
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Rare Power Limited
S30 and S31 of the 6th Floor of Building 17, No. 17 Science Park West Avenue, Pak Shek Kok, New Territories, Hong Kong
Hong Kong, Hong Kong 00000
Hong Kong

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-